INTRODUCTION AND SIGNIFICANCE
M alignant disease of the colon and the rectum are the most often human neoplasm and as such comprises 30% of all malignant diseases.Comparing with the malignant neoplasm of digestive tract, there are 50% of colon and rectum cancer. According to the "American Society Cancer", only lung cancer in men and breast cancer in women are more often than colon and rectal cancer. Rectal cancers comprises 50% of all colo-rectal malignant dieseases. The incidence is 17:100.000 citizens. The incidence in USA is from 11 .
THE AIM OF THE STUDY
The aim of this study is to point out the necessity of early diagnosis and protocolar oncological approach to the treatment of malignant disease of the final part of the colon which must be done before choosing any operative procedure in order to prevent postoperative morbidity. It is also important to pay attention to the significance of the preoperative estimation of the disease state, which has a great influence on the life expectancy after the operation and the quality of life.
MATERIAL AND METHODOLOGY
On the material of the Clinic for Abdominal Surgery at the Clinical Centre-University of Sarajevo, 406 patients with colon malignant diseases who had undergone interventions were examined by retrospective-prospective analysis, during the four year period (from 2006 to 2010). Out of the total, 261 (64.2%) patients had cancer of the final part of the colon. The sources of information were the history of diseases, operative protocols, tracking files of the specialist clinics as well as the methods of the dialogue. (Table 1) Analysing the diseases in the first two years (from 2007 to 2008) and comparing that scope with the one from the other two years (from 2009 to 2010), we noticed that there is a significant increase in the number of patients in the other two year period (114:147 cases). All statistics contribute to the increase of colon malignant disease. 1, 3, 4, 7, 9 Distribution of cancer of the final part of colon between the sexes (table 2) As jou can see from the table 3, male sex prevails. Dukes (ABC) and Manson or histological variant of TNM system (p1 -p4) are guides for choosing a kind of protocol treatment 3, 4, 12, 25 . In the state A and B1/2, there were 93 patients (35.6%) who were treated with primary surgical procedure. In the state C and D, there were 168 patients (64.36%) and 24 of them (9.2%) underwent interventions in emergency service and 144 of them (55.2%) were treated with neoadjuvant chemo and radiotherapy followed by inter-vention and radiotherapy. After the adequate diagnosic, every patient passes oncological consilium which prescribe the protocol of the treatment in order to heal, prevent the sys- . There were 248(95.0%) examples of Adenocarcinoma;12(4.6%) examples of mucinous adenocarcinoma (mucoid or colloid) and non-differential carcinoma. There was 1 lymphoma (0.4%). (Table 4) "Conditio sine equanon" is presented by: histologic type, histologic degree of the malignment and morphometric parametres (table 5) .
Bleeding in stool was detected in 72%, changes in the habits of bowel movements were detected in 64.4% and abdominal pain was detected in 77.4%. Increased values of tumour markers were present in all patients with extensive process or recidive (35%). Colonoscopy with biopsy were done to all examinees as well as virtual CT and NMR colonography. We point out a great diagnostic importance of NMR because of the affected meso rectal fascia. Tumour gradus I, II, as well as tumour state B without the affection of mesorectal fascia and lympho-glandula require primary surgical procedure and all other cases require adjuvant radio and chemotherapy followed by an operation 1, 3, 4, 5, 17, 19, 22 .
Radio-chemotherapy (RCT) and operative therapy of the rectal malignoma
In the treatment of malignant final part of the colon, we follow these recommendations (table 7): in the state of tumour UICC from 1 to 2 cm, we use local excision, in terms TER, TEM (transanal resection, transanal mucosectomy). In the state UICC II/III (resectabile) we indicate resective intervention followed by RKT. In progressive tumour state III: RCT + resection, alternative RCT + Resection + CT. In local relapse RT + Resection + IORT, alternative RCT + Resection + CT. Nowadays, we try to apply neodjuvant RT (25 Gy) in the treatment of the early state of the tumour.
While treating rectal cancer,we strictly follow the protocol of the treatment (table 6) .
The aim of the application of the neoadjuvant RT (radiotherapy) is: to reduce the percentage of the local recidive and advantage the number of survivors in resectable cancer, to reduce the tumour, make the resec-tion easier, to shorten the treatment and make the surgical treatment possible with non operative patients.
Neoaduvant therapy has to enable the sphincter-preservative procedure in low rectal carcinoma. It is performed as: short-lasting (25 Gy in 5 Fr) and /or/ long-lasting (50 Gy in 25 Fr). It can be combined ("sandwich"), intraoperative and transluminal 15, 16, 21 . Adjuvant RCT treatment like "gold standard". Operation whenever it is possible.
Out of the radical surgical procedures, there were 104 (39,8%) anterior-posterior rectal resections, 24 (9,2 %) rectal amputations, 27(10,3%) colo transversal-rectal anastomosis, and 29(11,1%) ultra-low colo transversalanal anastomosis and interspincter anastomosis. There were 5 (1,9%) transanal resections (table 7) .
In most of the cases, Hartman's procedure was applied in emergency service -44 (16,8%). Derivational colostomy was applied to 10 cases (3,8%) -in non opertive cases in emergency service because of the ileus. In the treatment of a malignant rectal disease, we strictly follow the oncological principle of tumour resection of the affected organ together with its lymph-vascular way (TME). Total meso rectal excision (TME) requires com-pletely removed rectum concoction with Denonvilliers fascia which shines shoothly on the concoction 1, 2, 3, 4, 5, 7, 8, 10 . Resection of the whole mesorectum (TME) is a sharp dissection under eye control between parietal and visceral rectal fascia ? "Holy plane" (figure 8).
Lymphadenectomy is always done in the treatment of all states of diseases which actually stops its expansion. We noted that it is followed by prolonged treatment and recovery. In rectal tumours we put the proximal rectali line on the transverse colon on the junction of left branch of the middle left colic artery and right branch of the lefr colic. We put the distal resective line in the middle and upper third of the rectum in the hight of the puborectal sling in terms of low colo rectal anastomosis. In more distal localizations, we do ultra low colo-anal, intersphin-cter anastomosis by hand or stapler. We specially pay attention to the preparation and preservation of the innervation responsible for sexual function as well as the function of urinary bladder 1, 2, 3, 4, 5, 7, 9, 12, 23 . In all the cases, preparation of hypogastric plexus and pudendal nerve (sexual an urinary function) are obligatory.
Out of all surgical comlications of the rectal cancer treatment, there were 5 (2,7%) dehiscencia anastomosis. There were 12 (6,5%) partial dehiscencia and 19 (8,8%) infections of the wound. There were 9 (4,4%) thromboembolic manifestations. Prognosis of the patients treated for rectal cancer depens on the early detection and strict application of the protocol of the treatment.
An adequate pre-operative screening, strictly implemented protocol of treatment, regular controls and monitoring of the patients greatly improve the treatment.
Treatment of malignant rectal diseases requires measures of primary and secondary prevention. It consists of : rectal touche (RT) once a year after the age of 40 as well as a a blood in stool test once a year, sigmoidoscopy and/or colonoscopy every 3 to5 years after the age 45. Genetic stool tests on APC gene mutations promises an effective screening.
CONCLUSION
Generally speaking, colon cancer has the highest morbidity rate of all carcinomas. In almost half of the patients with colo rectal cancer, the localization was done in the final part of the colon and the rectum. Successful treatment depends on the localization, biological tumour action, progression of the process and good knowledge of its surgical and radio-chemotherapeutic treatment. A strict application of the protocol of malignant disease treatment gives the chance for good results.
Surgery is the priority in the treatment of early disease stages (A i B), while stages C and D require neoadjuvant chemo and radiotherapy followed by the operation.
Team work and close cooperation of oncologic team of physicians (surgeons, gastroenterologists, pathologists, oncologists, radiotherapeutists) as well as respect for the protocol of the treatment are the most important factors of successful oncologic surgery.
SUMMARY
Maligna bolest debelog crijeva spada u naj~eš}e neoplazme ~ovjeka i obuhvata oko 30% svih tumora digestivnog trakta. Pritom, karcinom završnog dijela debelog crijeva (rektuma) ~ini 45-48% svih oboljelih od CRC (kolorektalnog karcinoma). Prema "American Society Cancer" samo rak plu}a i prostate u muškaraca i rad dojke i grli}a meternice u 'ena su ~eš}i od CRC. Incidenca kolorektalnog raka se kre}e od 15-30/100.000 stanovnika. Rektalni karcinom je rezultat poreme}enih genskih faktora u intereakciji sa ~iniocima spoljne sredine. Po~eci hirurškog lije~enja rektalnog karcinoma datiraju od Fageta, koji 1739. godine, izvodi prvu ekstraperitonealnu TME "HOLY PLANE " (Bill Heald, 1982) 
